Bessemer Securities’s AbbVie ABBV Stock Holding History

Bessemer Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,981	Closed	-$593K	–	3
2023 Q3	$593K	Sell	3,981 -6,794	-63%	-$997K	0.82%	30
2023 Q2	$1.45M	Sell	10,775 -1,050	-9%	-$154K	0.96%	26
2023 Q1	$1.89M	Sell	11,825 -100	-0.8%	-$15.3K	0.88%	36
2022 Q4	$1.93M	Buy	11,925 +700	+6%	+$107K	0.86%	37
2022 Q3	$1.51M	Buy	11,225 +800	+8%	+$115K	0.54%	48
2022 Q2	$1.6M	Hold	10,425	–	–	0.56%	46
2022 Q1	$1.69M	Hold	10,425	–	–	0.49%	57
2021 Q4	$1.41M	Buy	10,425 +2,060	+25%	+$243K	0.38%	75
2021 Q3	$902K	Hold	8,365	–	–	0.31%	80
2021 Q2	$942K	Buy	8,365 +650	+8%	+$73.2K	0.37%	74
2021 Q1	$835K	Hold	7,715	–	–	0.35%	72
2020 Q4	$827K	Hold	7,715	–	–	0.35%	31
2020 Q3	$676K	Hold	7,715	–	–	0.31%	36
2020 Q2	$757K	Buy	7,715 +1,800	+30%	+$158K	0.39%	31
2020 Q1	$451K	Sell	5,915 -135	-2%	-$11.5K	0.22%	65
2019 Q4	$536K	Hold	6,050	–	–	0.21%	71
2019 Q3	$458K	Hold	6,050	–	–	0.19%	78
2019 Q2	$440K	Hold	6,050	–	–	0.18%	81
2019 Q1	$488K	Hold	6,050	–	–	0.17%	77
2018 Q4	$558K	Buy	+6,050	New	+$532K	0.21%	73

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bessemer Securities's ABBV Position: Q4 2023 in Review

Bessemer Securities sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 3,981 shares — an estimated $593K sold.

Bessemer Securities first reported a position in ABBV in Q4 2018 and held it in 20 quarters. The position peaked at $1.93M in Q4 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

Bessemer Securities reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
Bessemer Securities sold 3,981 AbbVie shares in Q4 2023, an estimated $593K.
Bessemer Securities first reported a position in AbbVie in Q4 2018 and held it in 20 quarters.
Bessemer Securities's AbbVie position peaked at $1.93M in Q4 2022.
3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Bessemer Securities's 13F filing for Q4 2023.